Lazard, Inc. filed a current report with the Securities and Exchange Commission on November 6, 2026, disclosing the filing of a prospectus supplement covering the possible resale of up to 9,416,817 shares of common stock issued in connection with its acquisition of Campbell Lutyens Holdings Limited.

Key Highlights

  • Shares covered: Up to 9,416,817 shares of Lazard common stock, par value $0.01 per share, are covered by the prospectus supplement.
  • Acquisition connection: The shares were issued to selling stockholders in connection with the acquisition of one hundred percent of the outstanding ownership interests of Campbell Lutyens Holdings Limited.
  • Prospectus type: The supplement was filed pursuant to Rule 424(b) under the Securities Act of 1933, as amended.
  • Legal opinion: Sullivan & Cromwell LLP provided an opinion, filed as Exhibit 5.1, regarding the validity of the securities.
  • Signing officer: The report was signed by Shari L. Soloway, Deputy General Counsel, Chief Corporate Counsel & Corporate Secretary.

Lazard Registers Selling Stockholder Shares Tied to Campbell Lutyens Deal

According to the filing, Lazard, Inc. (NYSE:LAZ), a Delaware corporation headquartered at 30 Rockefeller Plaza in New York, filed a prospectus supplement on November 6, 2026, to facilitate the possible resale of up to 9,416,817 shares of its common stock. The company disclosed that these shares were previously issued to selling stockholders in connection with its acquisition of one hundred percent of the outstanding ownership interests of Campbell Lutyens Holdings Limited, which had been previously announced.

The prospectus supplement was filed pursuant to Rule 424(b) under the Securities Act of 1933, as amended. Lazard is a global financial advisory and asset management firm, and the Campbell Lutyens acquisition represents an addition to its advisory business. The filing noted that Sullivan & Cromwell LLP delivered a legal opinion, included as Exhibit 5.1, addressing the validity of the securities being registered for resale. The filing also stated that it "shall not constitute an offer to sell or the solicitation of an offer to buy" the covered securities.

The shares carry a par value of $0.01 per share and are listed on the New York Stock Exchange under the ticker symbol LAZ. The report was signed by Shari L. Soloway in her capacity as Deputy General Counsel, Chief Corporate Counsel & Corporate Secretary, and was dated November 6, 2026.

What Was Disclosed

Lazard disclosed the filing of a Rule 424(b) prospectus supplement covering up to 9,416,817 shares of common stock issued to selling stockholders as part of its acquisition of Campbell Lutyens Holdings Limited, along with a legal validity opinion from Sullivan & Cromwell LLP.